| 2023/06/07 22:00:00 | |
|---|---|
| Price | |
| 119.71 USD | |
| Difference | -4.52% (-5.67) |
General attributes
| ISIN | US2521311074 |
| Symbol | DXCM |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 43,341 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 119.00 USD (100) |
| Ask (Ask size) | 120.28 USD (100) |
| Open | 125.76 USD |
| High | 126.19 USD |
| Low | 117.74 USD |
| Close (prev. day) | 125.38 USD |
| VWAP | 120.349379 USD |
| Volume (pcs) | 3,099,561 |
| Trading volume | 373,152,167.42 |
| Number of trades | 55,415 |
| Last size | 395,887 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: DEXCOM INC. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2023/06/06 |
|
Global Equity Ratings |
|
| 2023/06/01 |
|
Global Equity Ratings |
|
| 2023/05/24 |
|
Global Equity Ratings |
|
| 2023/05/03 |
|
Global Equity Ratings |
|
| 2023/04/25 |
|
Global Equity Ratings |
|
| 2023/06/07 22:00:00 | |
|---|---|
| Price | |
| 119.71 USD | |
| Difference | -4.52% (-5.67) |
General attributes
| ISIN | US2521311074 |
| Symbol | DXCM |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 43,341 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 119.00 USD (100) |
| Ask (Ask size) | 120.28 USD (100) |
| Open | 125.76 USD |
| High | 126.19 USD |
| Low | 117.74 USD |
| Close (prev. day) | 125.38 USD |
| VWAP | 120.349379 USD |
| Volume (pcs) | 3,099,561 |
| Trading volume | 373,152,167.42 |
| Number of trades | 55,415 |
| Last size | 395,887 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +1.53% | +55.27% | +31.37% |
| Perf (abs.) | +1.80 | +42.61 | +28.59 |
| Beta | 0.95 | 1.21 | 1.35 |
| Volatility | 37.18 | 45.41 | 45.35 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 122.38 USD (2,884,131) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 119.47 USD (2,698,716) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 115.20 USD (2,404,708) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 103.35 USD (2,627,144) |
| YTD High | date | 126.59 USD (2023/06/06) |
| YTD Low | date | 102.50 USD (2023/01/25) |
| 52 Weeks High | date | 126.59 USD (2023/06/06) |
| 52 Weeks Low | date | 67.11 USD (2022/06/16) |
All listings for DEXCOM INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Vienna Stock Exchange | 2023/06/07 | 17:32 | 114.26 EUR | 0.00 | 2 |
| Tradegate | 2023/06/07 | 22:26 | 111.96 EUR | 0.07 | 16 |
| Stuttgart | 2023/06/07 | 21:58 | 111.70 EUR | 0.00 | 8 |
| Nasdaq | 2023/06/07 | 22:00 | 119.71 USD | 373.15 | 55,415 |
| Munich | 2023/06/07 | 08:00 | 116.62 EUR | 0.00 | 1 |
| London Stock Exchange | 2023/05/30 | 15:31 | 115.21 USD | 0.00 | 1 |
| Hanover | 2023/06/07 | 08:23 | 116.68 EUR | 0.00 | 1 |
| Hamburg | 2023/06/07 | 08:23 | 116.68 EUR | 0.00 | 1 |
| Frankfurt | 2023/06/07 | 08:20 | 116.68 EUR | 0.00 | 1 |
| Duesseldorf | 2023/06/07 | 08:10 | 116.58 EUR | 0.00 | 1 |
| Berlin | 2023/06/07 | 08:08 | 116.70 EUR | 0.00 | 1 |
| BX Swiss | 2023/04/20 | 18:00 | 110.28 CHF | 0.01 | 1 |
Company Logo
Contact Details
| DEXCOM INC. |
| - - |
| 6340 Sequence Drive - 92121 San Diego |
| Telefon: +1-858-200-0200 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: DEXCOM INC. | |
Company Profile
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA. |
Members of Management Board
| Barbara Kahn | Member of Board of Directors |
| Eric Topol | Member of Board of Directors |
| Bridgette Heller | Member of Board of Directors |
| Karen Dahut | Member of Board of Directors |
| Kyle Malady | Member of Board of Directors |
| Mark Foletta | Member of Board of Directors |
| Nicholas Augustinos | Member of Board of Directors |
| Richard Collins | Member of Board of Directors |
| Steven Altman | Member of Board of Directors |
| Kevin Sayer | Chairman of Managing Board |
| Andrew K. Balo | Member of Executive Committee |
| Barry Regan | Member of Executive Committee |
| Chad Patterson | Member of Executive Committee |
| Don Abbey | Member of Executive Committee |
| Jake Leach | Member of Executive Committee |
| Jereme Sylvain | Member of Executive Committee |
| Paul Flynn | Member of Executive Committee |
| Sadie Stern | Member of Executive Committee |
| Shelly Selvaraj | Member of Executive Committee |
| Steven R. Pacelli | Member of Executive Committee |
| Sumi Shrishrimal | Member of Executive Committee |